Provided by Tiger Trade Technology Pte. Ltd.

Harrow Health Inc

52.20
+1.382.72%
Volume:361.11K
Turnover:18.71M
Market Cap:1.93B
PE:-387.60
High:53.36
Open:50.51
Low:49.71
Close:50.82
52wk High:54.85
52wk Low:20.85
Shares:37.04M
Float Shares:27.23M
Volume Ratio:1.31
T/O Rate:1.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1347
EPS(LYR):-0.4903
ROE:-9.57%
ROA:4.91%
PB:41.12
PE(LYR):-106.46

Loading ...

Analysts Are Bullish on Top Healthcare Stocks: Harrow Health (HROW), NeoGenomics (NEO)

TIPRANKS
·
Feb 17

Harrow Launches PharmaPack Kits to Boost Access to FDA-Approved Eye Therapies

Reuters
·
Feb 17

Analysts Offer Insights on Healthcare Companies: Harrow Health (HROW), Icon (ICLR) and Perspective Therapeutics (CATX)

TIPRANKS
·
Feb 13

Analysts Offer Insights on Healthcare Companies: Treace Medical Concepts (TMCI) and Harrow Health (HROW)

TIPRANKS
·
Feb 09

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Feb 03

Harrow Gains After Reaffirming FY25 Revenue Guidance

Dow Jones
·
Feb 02

Lake Street Sticks to Their Buy Rating for Harrow Health (HROW)

TIPRANKS
·
Feb 02

Harrow Inc. Files Initial Beneficial Ownership Statement for Chief Commercial Officer Patrick William Sullivan

Reuters
·
Feb 02

GUIDANCE: (HROW) Harrow Expects 2025 Revenue Range $270M - $280M, vs. FactSet Est of $273.4M

MT Newswires Live
·
Feb 02

Harrow Reaffirms 2025 Revenue Guidance of $270–$280 Million

Reuters
·
Feb 02

Harrow Reaffirms 2025 Full-Year Revenue Guidance of $270–$280 Million, Marking Another Year of Strong Growth

THOMSON REUTERS
·
Feb 02

Harrow Currently Down Eight Consecutive Days, on Pace for Longest Losing Streak Since January 2022 -- Data Talk

Dow Jones
·
Jan 29

Is Harrow's (HROW) Softer 2025 Outlook Exposing a Fragile Revenue Mix Strategy?

Simply Wall St.
·
Jan 14

Evaluating Harrow (HROW) After Recent Share Price Swings And Long Term Return Strength

Simply Wall St.
·
Jan 10

Opaleye Management Inc. Reports Disposal of Harrow Inc. Common Shares

Reuters
·
Jan 09

Does Harrow’s Recent FDA News Signal an Opportunity After a 7.5% Decline?

Simply Wall St.
·
Nov 24, 2025

Harrow Health (HROW) Receives a Buy from Lake Street

TIPRANKS
·
Nov 18, 2025

Harrow Closes Melt Pharmaceuticals Acquisition

MT Newswires Live
·
Nov 18, 2025

Harrow Announces Closing of Acquisition of Melt Pharmaceuticals

THOMSON REUTERS
·
Nov 18, 2025

Stock Track | Harrow Health (HROW) Soars 5.03% as Multiple Analysts Raise Price Targets

Stock Track
·
Nov 12, 2025